Incepta Pharmaceuticals
Incepta introduces Papilovax, vaccine for cervical cancer
The Papilovax vaccine protects against cervical cancer by preventing the HPV virus responsible for cervical cancer.
18 July 2022
Detecting cholera in 15 minutes
Scientists at the icddr,b, in partnership with Incepta Pharmaceuticals, have developed a low-cost device which can detect cholera in only 15 minutes.
12 March 2019
icddr,b develops law cost rapid diagnostic test kit for cholera
Scientists at the icddr,b, in partnership with Incepta Pharmaceuticals, have developed a locally-made low-cost dipstick device -- Cholkit -- for rapid and effective diagnosis of cholera, generating new hopes of better management the disease.
12 March 2019